RxDoctor Payments Data

William David, MD

Neurology · Boston, MANPI 1750333605

Payments from drug & device makers

$45,205in general payments, 2019–2025

Across 39 payments — averaging $1159.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$39K
  • Natus Medical Incorporated$5K
  • UCB, Inc.$1K
  • Seqirus USA Inc$16

What the payments were for

  • Consulting fees$39,45087%
  • Speaking & faculty fees$4,68910%
  • Food & beverage$1,0672%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer22$39,450
Natus Medical Incorporated1$4,689
UCB, Inc.15$1,050
Seqirus USA Inc1$16

How this compares

$45,205 in reported general payments places this provider in the 75th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$165,626
Medicare patients
218
Services billed
14,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Radicava OrsEdaravone11$149,102

Paid to pharmacies, not to this prescriber.

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →